This study was designed to show whether placental relaxin (RLN), its receptor (RXFP1), or insulin-like peptide 4 (INSL4) might have altered expression in patients with placenta accreta. The baseline expression of their genes through gestation (n = 34) was quantitated in the placental basal plate (BP) and villous trophoblast (TR), and compared to their expression in placenta accreta (n = 6). The proteins were also immunolocalized and quantitated in the accreta tissues. The messenger RNAs (mRNAs) of matrix metalloproteinase 9, -2, and tissue inhibitors of matrix metalloproteinase (TIMP)-1 were also measured. Results demonstrated that the BP and TR expressed low levels of RLN/RXFP1 and INSL4 through gestation. In accreta, increased RLN gene and protein in BP were associated with antepartum bleeding whereas INSL4 expression decreased throughout the TR. There were no changes in mRNAs for MMPs, but TIMP-1 was increased only in the invasive TR.
KempBKertschanskaSKadyrovMRathWKaufmannPHuppertzB. Invasive depth of extravillous trophoblast correlates with cellular phenotype: a comparison of intra- and extrauterine implantation sites. Histochem Cell Biol. 2002;117(5):401–414.
2.
NessRSibaiB. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195(1):40–49.
3.
BelfortMA.Publications committee, society for maternal-fetal medicine. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430–439.
TantbirojnPCrumCParastM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008;29(7):639–645.
6.
JauniauxEJurkovicD. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012;33(4):244–251.
7.
BernirschkeKKaufmannPBaergenR. Pathology of the Human Placenta. 5th ed. New York, NY; Springer; 2006.
8.
CravenCChedwickLWardK. Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblastic cell invasion. Am J Obstet Gyneceol. 2002;186(2):291–296.
9.
StanekJDrummondZ. Occult placenta accreta: the missing link in the diagnosis of abnormal placentation. Pediatr Dev Pathol. 2007;10(4):266–273.
10.
TsengJChouM. Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta. Taiwan J Obstet Gynecol. 2006;45(2):100–106.
11.
HanVBassetNWaltonJChallisJ. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGRBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab. 1996;81(7):2680–2693.
12.
CrawfordRHudsonPShineJNiallHEddyRShowsT. Two human relaxin genes are on chromosome 9. EMBO J. 1984;3(10):2341–2345.
13.
BathgateRSamuelCBurazinTHuman relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem. 2002;277(2):1148–1157.
14.
Garibay-TupasJMaaskantRGreenwoodFBryant-GreenwoodG. Characteristics of the binding of 32P-labelled human relaxins to the human fetal membranes. J Endocrinol. 1995;145(3):441–448.
15.
BogicLYamamotoSMillarLBryant-GreenwoodG. Developmental regulation of the human relaxin genes in the decidua and placenta: overexpression in the preterm premature rupture of the fetal membranes. Biol Reprod. 1997;57(4):908–920.
16.
TashimaLYamamotoSYasudaMMillarLBryant-GreenwoodG.Decidual relaxins: gene and protein up-regulation in preterm premature rupture of the membranes by complementary DNA arrays and quantitative immunocytochemistry. Am J Obstet Gynecol. 2002;187(3):785–797.
17.
Bryant-GreenwoodGKernAYamamotoSSadowskyDNovyM. Relaxin and the human fetal membranes. Reprod Sci. 2007;14(suppl 8):42–45.
18.
UnemoriENEriksonMERoccoSERelaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum Reprod. 1999;14(3):800–806.
19.
LowndesAmano AYamamotoSBryant-GreenwoodG.The human relaxin receptor (LGR7): expression in the fetal membranes and placenta. Placenta. 2006;27(6-7):610–618.
20.
ChassinDLaurentAJanneauJBergerRBelletD. Cloning of a new member of the insulin gene superfamily (INSL4) expressed in human placenta. Genomics. 1995;29(2):465–470.
21.
LaurentARouillacCDelezoideAInsulin-like 4 (INSL4) gene expression in human embryonic and trophoblastic tissues. Mol Reprod Dev. 1998;51(2):123–129.
22.
BrandtBRoetgerABidartJEarly placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential. Cancer Res. 2002;62(4):1020–1024.
23.
CohenMMeisserABischofP. Metalloproteinases and human placenta invasiveness. Placenta. 2006;27(8):783–793.
24.
Demir-WeustenASevalYKaufmannPDemirRYucelGHuppertzB. Matrix metalloproteinases-2, -3 and -9 in human term placenta. Acta Histochem. 2007;109(5):403–412.
25.
TarradeAGoffinFMunautCEffect of matrigel on human extravillous trophoblasts differentiation: modulation of protease pattern gene expression. Biol Reprod. 2002;67(5):1628–1637.
26.
MoserGOrendiKGausterMSiwetzMHeligeCHuppertzB. The art of identification of extravillous trophoblast. Placenta. 2011;32(2):197–199.
27.
LinFOtvosLJr KumagaiJTregearGWBathgateRAWadeJD. Synthetic human insulin 4 does not activate the G-protein coupled receptors LGR7 or LGR8. J Pept Sci. 2004;10(5):257–264.
28.
BiecheILaurentALaurendaeauIPlacenta-specific INSL4 expression is mediated by a human endogenous retrovirus element. Biol Reprod. 2003;68(4):1422–1429.
29.
BruniLLuisiSFerrettiC. Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy. Am J Obstet Gynecol. 2007;197(6):606.e1–e4.
30.
SmithSBakerPSymondsE. Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol. 1997;177(1):57–65.
31.
MillarLStreinerNWebsterLEarly placental insulin-like protein (INSL4 or EPIL) in placental and fetal membrane growth. Biol Reprod. 2005;73(4):695–702.
32.
SeiboldJRKornJSimmsRControlled trial of recombinant human relaxin (rhRLXN) in diffuse scleroderma (DS). Arthritis Rheum. 1997;40:S123.
33.
ConradKShroffS. Effects of relaxin on arterial dilation, remodeling and mechanical properties. Curr Hypertens Rep. 2011;13(6):409–420.
34.
AntlMvon BruhlMEiglspergerCIRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood. 2007;109(2):552–559.
35.
BaniDNistriSCinciLA novel, simple bioactivity assay for relaxin based on inhibition of platelet aggregation. Regul Pept. 2007;144(1-3):10–16.
36.
IsakaKUsudaSItoHExpression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta. 2003;24(1):54–64.
37.
BullesbachESchwabeC. Synthesis and conformational analysis of the insulin-like 4 gene product. J Pept Res. 2001;57(1):77–83.
38.
KayHNelsonDWangY.The Placenta. From Development to Disease. 1st ed. Chichester, UK: Blackwell Publishing Ltd, 2011:20–36.
